Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

TransMedics (TMDX) Accumulated Depreciation & Amortization (2018 - 2025)

TransMedics (TMDX) has 8 years of Accumulated Depreciation & Amortization data on record, last reported at $60.6 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 71.9% year-over-year to $60.6 million; the TTM value through Sep 2025 reached $60.6 million, up 71.9%, while the annual FY2024 figure was $40.7 million, 91.21% up from the prior year.
  • Accumulated Depreciation & Amortization reached $60.6 million in Q3 2025 per TMDX's latest filing, up from $53.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $60.6 million in Q3 2025 and bottomed at $9.7 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $35.2 million, with a median of $38.0 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 21.28% in 2021, then surged 91.21% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $9.7 million in 2021, then skyrocketed by 34.86% to $13.1 million in 2022, then surged by 62.18% to $21.3 million in 2023, then soared by 91.21% to $40.7 million in 2024, then soared by 48.79% to $60.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $60.6 million in Q3 2025, $53.8 million in Q2 2025, and $46.9 million in Q1 2025.